
Feature|Videos|August 25, 2023
Discussing the State of Pharma with Congressman Adam Smith
Author(s)Grant Playter
Adam Smith, a House of Representatives member representing Washington's 9th congressional district, discusses the state of U.S. healthcare and pharma.
Advertisement
Adam Smith, a House of Representatives member representing Washington's 9th congressional district, chats with Grant Playter, associate editor, to discuss the state of U.S. healthcare and pharma. Topics of discussion include Adam's memoir and own struggles with the healthcare system, balancing the competing demands of innovation and pricing, and the role of the judicial system with regards to FDA oversight.
Advertisement
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
Europe Tried to Ban Generative AI From Critical GMP. The Ban May Not Survive. It Does Not Matter.
2
What Does TAUKLARIFY's Approval Mean for Alzheimer's Drug Developers?
3
Pharma's AI ROI Problem Isn't a Tech Problem but a Qualification Problem
4
Danish Biotechs Attracting Investor Attention
5



